dc.creatorIslan, Germán Abel
dc.creatorBosio, Valeria Elizabeth
dc.creatorCastro, Guillermo Raúl
dc.date2013
dc.date2023-05-18T17:06:21Z
dc.date.accessioned2023-07-15T10:35:12Z
dc.date.available2023-07-15T10:35:12Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/153221
dc.identifierissn:1616-5195
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7492428
dc.descriptionA new formulation is described based on biopolymeric microspheres containing alginate lyase (AL) and ciprofloxacin (Cip) for sustainable oral delivery in CF patients. Alginate (ALG) and high-methoxyl pectin (HMP) are selected as the biopolymers to develop a composite matrix. ALG microspheres coated with HMP and ALG-HMP blend are gelled in water/organic solvents mixtures, obtaining Cip encapsulations from 46.0 to 100.0%. ALG-HMP shows a Cip sustainable release profile and is able to encapsulate 90.0% of AL, showing 76.0% enzyme activity after release under simulated intestinal conditions. The developed system is a promising delivery carrier to treat chronic infection of Pseudomonas aeruginosa and to reduce the viscoelasticity of the mucus accumulated into intestine of CF patients.
dc.descriptionCentro de Investigación y Desarrollo en Fermentaciones Industriales
dc.formatapplication/pdf
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.subjectBiología
dc.subjectalginate lyase
dc.subjectBiopolymers
dc.subjectCiprofloxacin
dc.subjectCystic fibrosis
dc.subjectDrug delivery
dc.titleAlginate lyase and ciprofloxacin co-immobilization on biopolymeric microspheres for cystic fibrosis treatment
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución